The US Centers for Disease Control and Prevention (CDC) on Friday said the bivalent COVID-19 vaccine “performed well against COVID-19-associated hospitalisation in older adults”, a study found. The study was conducted by the National Center for Injury Prevention and Control and the CDC’s National Center for Immunization and Respiratory Diseases.